Granoff et al. J. Immunol. 160: 5028-5036, 1998. |
Kabat et al. J. Exp. Med. 164: 642-654, 1986. |
Livingston et al. J. Biol. Chem. 263: 9443-9448, 1988. |
Bitter-Suermann et al. Immunol. Res. 225-237, 1987. |
Tome et al. Acta Pathol. Jpn. 43: 168-175, 1993. |
Vaesen et al. Biol. Chem. Hoppe. Seyler 372: 451-453, 1991. |
Klebert et al. Biol. Chem. Hoppe Seyler 374: 993-1000, 1993. |
Pon et al. J. Exp. Med. 185: 1929-1938, Jun. 1997. |
Baumann et al. Biochemistry 32: 4007-4013, 1993. |
Sato et al. J. Biol. Chem. 270: 18923-18928, 1995. |
FE Ashton et al. Mibrob. pathogenesis 6: 455-458 (Cited as reference A), 1989. |
FE Ashton et al. In: Neisseria 1990, Achtman M (Ed.), Walter De Gruyter & Co., Berlin, pp. 187-191 (Cited as reference B), 1991. |
K. Sukkonen et al. Mibrobial Pathogenesis 1: 101-105, 1986. |
Lifely et al. Immunology 74: 490-496, 1991. |
G Rougon et al. J. Cell Biol. 103: 2429-2437, 1986. |
HV Raff et al. J. Infect. Dis. 157 (1): 118-126, 1988. |
CM Hurpin et al. Hybridoma 11 (6): 677-687, 1992. |
M Husmann et al. J. Histochem. Cytochem. 38: 209-215, 1990. |
A Bartoloni et al. Vaccine 13 (5): 463-470, 1995. |
C Moreno et al. J. Gen. Microbiol. 129: 2451-456, 1983. |
AS Cross et al. J. Infect. Dis. 147 (1): 68-76, 1983. |
M Leinonen et al. Infect. immun. 38 (3): 1203-1207, 1982. |
M Frosch et al. PNAS 82: 1194-1198, 1985. |
NA Gregson et al. Biochem. Soc. Transact. 13: 462, 1985. |
Devi et al. In: Neisseria: Proc. Ninth Internat. Pathogenic Neisseria Conference FEMS Immunol. Med. Microbiol. Evans et al. (Ed.), S.C.C., England, pp. 427-429, 1994. |
Devi et al. FEMS Immunol. Med. Microbiol. 14 (Jul.): 211-220, 1996. |
Westerink et al., "Development and Characterization of an Anti-idiotype Antibody to the Capsular Polysaccharide of Neisseria Mengingitidis Serogroup C," Infection and Immunity 56(5):1120-1127 (1988). |
Horwell, David C., "The `Peptoid` Approach to the Design of Non-Peptide, Small Molecule Agonist and Antagonists of Neuropeptides," TIBTech 13 (4):132-134 (1995). |
Brisson et al., "Helical Epitope of the Group B Meningococcal .alpha.(2-8)-Linked Sialic Acid Polysaccharide," Biochemistry 31:4996-5004 (1992). |
Dubois et al., "A Monoclonal Antibody Against Meningococcus Group B Polysaccharides Used to Immunocapture and Quantify Polysialylated NCAM in Tissues and Biological Fluids," Journal of Immunological Methods 181:125-135 (1995). |
Frasch, Carl E., "Meningococcal Vaccines: Past, Present and Future," Meningococcal Disease 245-283 (1995). |
Fusco et al., "Preclinical Evaluation of a Novel Group B Meningococcal Conjugate Vaccine that Elicits Bactericidal Activity in Both Mice and Nonhuman Primates," The Journal of Infectious Disease 175:364-372 (1997). |
Granoff et al., "Antibody Responses to the Capsular Polysaccharide of Neisseria Menignitidis Serogroup B in Patients With Meningcoccal Disease," Clinical and Diagnostic Laboratory Immunology 2(5):574-582 (1995). |
Hayrinen et al., "Antibodies to Polysialic Acid and its N-Propyl Derivative: Binding Properties and Interaction with Human Embryonal Brain Glycopeptides," The Journal Of Infectious Diseases 171:1481-1490 (1995). |
Jennings, Harold J., "The Capsular Polysaccharide of Group B Neisseria Meningitidis as a Vehicle for Vaccine Development," Microbiol. Immunol. 10:151-165 (1989). |
Jennings et al., "Induction of Meningococcal Group B Polysaccharide-Specific IgG Antibodies in Mice by Using an N-Propionylated B Polysaccharide-Tetanus Toxoid Conjugate Vaccine," The J. Of Immunology 137(5):1708-1713 (1986). |
Jennings et al., "N-Polysialic Group B Meningococcal Polysaccharide Mimic a Unique Epitope on Group B Neisseria Meningitidis," J. Experimental Medicine 165:1207-1211 (1987). |
Jennings et al., "Unique Intermolecular Bactericidal Epitope Involving the Homosialopolysaccharide Capsule on the Cell Surface of Group B Neisseria Meningitidis and Escherichia Coli K1," Journal of Immunology 142(10):3585-3591 (1989). |
Jennings et al., "Immunochemistry of Groups A,B, and C Meningococcal Polysaccharide-Tetanus Toxoid Conjugates," The Journal of Immunology 127(3):1011-1018 (1981). |
Lucas et al., "Functional Differences in Idiotypically Defined IgG1 Anti-Polysaccharide Antibodies Elicited by Vaccination with Haemophilus Influenzae Type B Polysaccharide-Protein Conjugates," The Journal of Immunology 154:4195-4202 (1995). |
Mandrell et al., "Complement-Mediated Bactericidal Activity of Human Antibodies in Poly W .alpha.2.fwdarw.8 N-Acetylneuraminic Acid, the Capsular Polysaccharide of Neisseria Meningitidis Serogroup B," The Journal of Infectious Diseases 172:1279-1289 (1995). |
Michon et al., "Conformational Differences Between Linear .alpha.(2.fwdarw.8)-Linked Homosialooligosaccharides and the Epitope of the Group B Meningococcal Polysaccharide," Biochemistry 26:8399-8405 (1987). |
Poolman, Jan T., "Development of a Meningococcal Vaccine," Infectious Agents and Disease 4:13-28 (1995). |
DataBase WPI., "Novel Strain of Neisseria Meningitidis Group Useful Produce Capsule Polysaccharide Protein Complex," Jan. 30, 1992. |